ReviewWiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
Nanomedical engineering: shaping future nanomedicines.
Review in Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed.
- Beyond apoptosis: nanomedicine enabled reprogramming of tumor cell death for next-generation radiosensitization.Journal of nanobiotechnology · 2026Review
- Review
- Small molecule-induced DNA hydrogel with encapsulation and release properties.Chemical communications (Cambridge, England) · 2020Article
- Switchable Fluorescence of Doxorubicin for Label-Free Imaging of Bioorthogonal Drug Release.ChemMedChem · 2020Article
- Liposomal formulations of photosensitizers.Biomaterials · 2019Review
- Improved Efficacy and Reduced Toxicity Using a Custom-Designed Irinotecan-Delivering Silicasome for Orthotopic Colon Cancer.ACS nano · 2019Article
- Loading and Releasing Ciprofloxacin in Photoactivatable Liposomes.Biochemical engineering journal · 2019Article
- Metalloporphyrin Nanoparticles: Coordinating Diverse Theranostic Functions.Coordination chemistry reviews · 2019Article
- Binding of an amphiphilic phthalocyanine to pre-formed liposomes confers light-triggered cargo release.Journal of materials chemistry. B · 2018Article
- Naphthalocyanines as contrast agents for photoacoustic and multimodal imaging.Biomedical engineering letters · 2018Review
- Understanding the Pathological Basis of Neurological Diseases Through Diagnostic Platforms Based on Innovations in Biomedical Engineering: New Concepts and Theranostics Perspectives.Medicines (Basel, Switzerland) · 2018Article
- A dual-channel endoscope for quantitative imaging, monitoring, and triggering of doxorubicin release from liposomes in living mice.Scientific reports · 2017Article
- Controlled in-cell activation of RNA therapeutics using bond-cleaving bio-orthogonal chemistry.Chemical science · 2017Article
- Advanced Functional Nanomaterials for Theranostics.Advanced functional materials · 2017Article
- Targeted Nanomaterials for Phototherapy.Nanotheranostics · 2017Review
- Recent applications of phthalocyanines and naphthalocyanines for imaging and therapy.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2017Review
- Liposomal Nanoparticles Carrying anti-IL6R Antibody to the Tumour Microenvironment Inhibit Metastasis in Two Molecular Subtypes of Breast Cancer Mouse Models.Theranostics · 2017Article
- Chemophototherapy: An Emerging Treatment Option for Solid Tumors.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2017Review
- Early Development Challenges for Drug Products Containing Nanomaterials.The AAPS journal · 2017Article
- Mechanisms of Light-induced Liposome Permeabilization.Bioengineering & translational medicine · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Preclinical research in the field of nanomedicine continues to produce a steady stream of new nanoparticles with unique capabilities and complex properties. With improvements come promising treatments for diseases, with the ultimate goal of clinical translation and better patient outcomes compared with current standards of care. Here, we outline engineering considerations for nanomedicines, with respect to design criteria, targeting, and stimuli-triggered drug release strategies. General properties, clinical relevance, and current research advances of various nanomedicines are discussed in light of how these will realize their potential and shape the future of the field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.